<DOC>
	<DOCNO>NCT01064271</DOCNO>
	<brief_summary>A Single-dose , Randomized , two-Period , Cross Study</brief_summary>
	<brief_title>Risperidone Tablets , 1 mg Bioequivalence Study Dr.Reddy 's Under Fed Condition</brief_title>
	<detailed_description>Randomized , single-dose , two-treatment , two-way , crossover study conduct compare relative bioavailability two risperidone 1 mg tablet formulation Fed condition . The test formulation Dr. Reddy 's Laboratories Limited 's 1 mg Risperidone tablet , reference formulation Risperdal® ( risperidone ) 1 mg tablet ( Janssen Pharmaceutica Products , L.P. ) . The study conduct 26 healthy adult . In study period , single 1 mg dose administer subject follow standardized high-fat breakfast precede overnight fast least 10 hour . The subject receive test product one study period reference product period ; order administration accord dose randomization schedule . There 7-day interval treatment .</detailed_description>
	<mesh_term>Risperidone</mesh_term>
	<criteria>1 . Males female , 18 55 year age . 2 . Female subject child bear potential must either abstain sexual intercourse use reliable method contraception ( e.g . condom spermicide , IUD , hormonal contraceptive ) least 30 day prior dose duration study . 3 . A body mass index ( BMI ) 1830 kg/m² inclusive calculate accord Novum Standard Operating Procedures . 4 . Good health determine lack clinically significant abnormality health assessment perform screen . 5 . Signed date informed consent form , meet criteria current FDA regulation . 1 . If female , pregnant , lactate likely become pregnant study . 2 . History allergy sensitivity risperidone , similar drug , history drug hypersensitivity intolerance , opinion Investigator , would compromise safety subject study . 3 . Significant history current evidence chronic infectious disease , system disorder organ dysfunction . 4 . Presence gastrointestinal disease history malabsorption within last year . 5 . History psychiatric disorder occur within last two year require hospitalization medication . 6 . Presence medical condition require regular treatment prescription drug . 7 . Use pharmacologic agent know significantly induce inhibit drugmetabolizing enzyme within 30 day prior initial dosing . 8 . Receipt drug part research study within 30 day prior dose . 9 . Drug alcohol addiction require treatment past 12 month . 10 . Donation significant loss whole blood ( 480 ml ) within 30 day plasma within 14 day prior dose . 11 . Positive test result HIV , Hepatitis B surface antigen , Hepatitis C antibody . 12 . Positive test result drug abuse screen . 13 . Positive serum pregnancy test . 14 . Subjects smoke 10 cigarettes/day equivalent tobacco use . 15 . Subjects special diet 28 day prior dose 16 . Subjects consume average 3 unit alcohol/day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>